NCT02870764

The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris

A Randomized, Double-blind, Placebo-controlled Trial of Dan-shen Extract in Patients With Stable Angina Pectoris

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 156 (estimated)
• Sponsor: Taizhou Fourth People's Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, double-blind, placebo-controlled, adaptive clinical trial, which will assess the effect of DanshenDuofensuanyan\[Danshen (a kind of Chinese herbal drug) extract\] treatment on Lipoprotein associated phospholipase A2 level in patients with stable angina pectoris.

Conditions

• Angina, Stable
• Inflammation

Interventions

Type	Name	Description
DRUG	Dan-shen extract	A kind of injection made from a kind of Chinese herb: salvia miltiorrhiza
DRUG	Placebo	200mg glugose added into 250ml 0.9% saline injection by an independent research nurse, sealed with brown bag in order to make the investigators and patients blinded, using brown infusion tube for infusion.
OTHER	Standard medical care	Standard medical care is in accordance with China Guideline for the diagnosis and treatment of Chronic Stable Angina (2007).

Timeline

• Start date: 2016-09-01
• Primary completion: 2017-05-01
• Completion: 2017-08-01
• First posted: 2016-08-17
• Last updated: 2016-09-13

Locations

1 site across 1 country: China